Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Eyenovia, Inc. EYEN
$3.42
-$0.56 (-16.30%)
На 18:01, 12 мая 2023
Ранг: 3
Ключевые показатели
-
Marketcap
153111790.00000000
-
week52high
5.85
-
week52low
1.50
-
Revenue
0
-
P/E TTM
-5
-
Beta
1.69307900
-
EPS
-0.88000000
-
Last Dividend
0.00000000
-
Next Earnings Date
10 мая 2023 г. в 10:59
Описание компании
Eyenovia, Inc., a clinical stage ophthalmic company, engages in developing therapeutics based on its proprietary microdose array print platform technology. The company focuses on developing clinical microdosing of formulations of ophthalmic pharmaceutical agents using its Optejet branded targeted ocular delivery system. It focuses on the development of therapeutic indications for patients with progressive myopia and age-related near vision impairment or presbyopia indications; and microdose fixed combination ophthalmic pharmaceutical for mydriasis to address the eye exams with pupil dilation. The company's product candidates include MicroLine, which is in Phase III clinical development program with indications for the improvement in near vision in people with presbyopia; MicroPine, which is in Phase III clinical development program with indications for pediatric myopia progression (near-sightedness); and MydCombi, which is in Phase III clinical development program with indications for pharmaceutical mydriasis. It has a license agreement with Bausch Health Ireland Limited to develop and commercialize MicroPine in the United States and Canada; and a license agreement with Arctic Vision (Hong Kong) Limited to develop and commercialize MicroPine and MicroLine in China and South Korea. The company was formerly known as PGP Holdings V, Inc. and changed its name to Eyenovia, Inc. in May 2014. Eyenovia, Inc. was incorporated in 2014 and is headquartered in New York, New York.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| HC Wainwright & Co. | Buy | Buy | 01 апр 2021 г. |
| HC Wainwright & Co. | Buy | Buy | 23 окт 2020 г. |
| Roth Capital | Buy | Buy | 14 окт 2020 г. |
| HC Wainwright & Co. | Buy | Buy | 13 авг 2020 г. |
| H.C. Wainwright | Buy | Buy | 26 мар 2020 г. |
| HC Wainwright & Co. | Buy | 05 окт 2022 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| GANDOLFO JOHN P | A | 68235 | 68235 | 17 янв 2023 г. |
| Kern Bren | A | 120000 | 120000 | 03 янв 2023 г. |
| Rowe Michael M | A | 15500 | 10000 | 30 дек 2022 г. |
| Grant Stuart M. | A | 5106751 | 21753 | 30 дек 2022 г. |
| Strahlman Ellen R | A | 43052 | 6686 | 31 авг 2022 г. |
| Strahlman Ellen R | A | 36366 | 6744 | 30 авг 2022 г. |
| Strahlman Ellen R | A | 29622 | 7931 | 29 авг 2022 г. |
| Strahlman Ellen R | A | 21691 | 1504 | 24 авг 2022 г. |
| Ianchulev Tsontcho | A | 30399 | 30399 | 18 авг 2022 г. |
| Ianchulev Tsontcho | A | 601211 | 21316 | 18 авг 2022 г. |
Новостная лента
Eyenovia to Report First Quarter 2023 Results on Thursday, May 11
GlobeNewsWire
04 мая 2023 г. в 08:00
Company to host an investor conference call and webcast at 4:30pm EDT Company to host an investor conference call and webcast at 4:30pm EDT
Eyenovia, Inc. (EYEN) Q4 2022 Earnings Call Transcript
Seeking Alpha
30 мар 2023 г. в 20:44
Eyenovia, Inc. (NASDAQ:EYEN ) Q4 2022 Results Conference Call March 30, 2023 4:30 PM ET Company Participants Eric Ribner - IR Michael Rowe - CEO John Gandolfo - CFO Bren Kern - COO Operator Greetings, and welcome to the Eyenovia Fourth Quarter and Full Year 2022 Earnings Call. [Operator Instructions] As a reminder, this conference is being recorded.
Eyenovia to Report Fourth Quarter and Full-Year 2022 Results on Thursday, March 30
GlobeNewsWire
23 мар 2023 г. в 08:00
Company to host an investor conference call and webcast at 4:30 pm ET Company to host an investor conference call and webcast at 4:30 pm ET
Eyenovia: Countdown To May 8, 2023
Seeking Alpha
25 февр 2023 г. в 03:36
I will update my previous two articles about Eyenovia. NDA accepted with no outside advisory committee formed to review their submission.
Hoping Eyenovia Has The Aye Votes From The FDA In The Near Future (Rating Downgrade)
Seeking Alpha
13 дек 2022 г. в 01:27
I will update the history I've had with Eyenovia. I will share with the reader the interim and pending events since my previous article.